BD1 in its current incarnation is the result of a reverse takeover of an ASX listed gold mining corporation called Eurogold. In 2016 Eurogold bought BD1AG(the Swiss(?) company that was founded by Dr Irminger-Finger) and by doing so, relisted as BD1 on the ASX.
BD1AG holds and BD1 now holds the exclusive license to commercially exploit the patents relating to the BARD1 tests. The patents were initially lodged by University De Geneve and Dr Irminger Finger. IIRC the University received quite a few shares in the new BD1 and they are one of the top 20 holders.
At least that's my understanding from reading the prospectus:
https://www.asx.com.au/asxpdf/20160407/pdf/436clf8h8q4ck2.pdf
BARD1 only got the patent grant advice today, page-30
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.005(1.06%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.5¢ | 46.5¢ | $14.73K | 31.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31493 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 5342 | 1 |
View Market Depth
| Last trade - 12.30pm 08/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |